Comparison 2. Nicotine EC versus varenicline.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
2.1 Smoking cessation | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2.2 Serious adverse events | 1 | 54 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |
2.2.1 12 weeks | 1 | 54 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |